An Open-label Therapeutic Efficacy Study of Tirosint (Levothyroxine Sodium) Capsules in Thyroidectomized Patients Taking Proton Pump Inhibitors
Phase of Trial: Phase IV
Latest Information Update: 28 Jan 2019
At a glance
- Drugs Levothyroxine sodium (Primary)
- Indications Hypothyroidism
- Focus Therapeutic Use
- Sponsors IBSA
- 31 Aug 2018 Biomarkers information updated
- 07 Aug 2018 Planned End Date changed from 1 Mar 2018 to 1 Jul 2019.
- 07 Aug 2018 Planned primary completion date changed from 1 Mar 2018 to 1 Jul 2019.